Insights & Resources

Get ahead of the curve by looking back at emerging trends in 2025 that are likely to impact health care valuation in 2026 and beyond. Download Weaver Insights now.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.

PET, CT and MRI volumes are accelerating. Learn what uneven imaging growth means for valuation and long-term planning.

Growth strategies in behavioral health are shifting. Learn how leaders can respond to industry headwinds and optimize performance effectively.

Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.

Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.

The OBBBA revives 100% bonus depreciation and introduces new deductions for qualified production property and manufacturing.

Health care providers face rising risks in privacy, AI and HIPAA enforcement. Find out what hospitals can do now to strengthen compliance efforts.

Learn how process level risk assessments for health care organizations leads to stronger governance, improved patient safety and better performance.

North Carolina’s top business ranking highlights the value of smart incentives and pro-growth policies for companies seeking long-term success.

Mobile medical units or construction office trailers may qualify businesses for off-highway fuel use credits, reducing tax burdens and saving money.

Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.